Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a 13-Week therapy program ease anxiety for dialysis patients?

NCT ID NCT07628309

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused This study
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 09, 2026 · Updated 3 times

Summary

This pilot study tests a 13-week Dialectical Behavioural Therapy (DBT) skills training program for Canadians who have recently started or will soon start facility-based hemodialysis. The goal is to see if the program is feasible and helpful for improving mental health and reducing anxiety. About 35 participants will attend weekly group sessions, either in person or virtually.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Dialectical Behavioural Therapy (DBT) skills training
What this could lead to
If successful, this could point toward a practical way to support mental health and reduce anxiety for people undergoing hemodialysis.
What could go wrong
This is a very small pilot study with only 35 participants, so results may not apply to everyone. It is testing feasibility, not yet proven to improve mental health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 35 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \> 18 years old * Individuals followed in the Manitoba Kidney Health Program at Seven Oaks General Hospital or Health Sciences Centre sites with advanced chronic kidney disease not yet on facility-based hemodialysis but with plans to start within 1 month; OR * Individuals followed in the Manitoba Kidney Health Program at the SOGH or HSC sites who have initiated facility-based hemodialysis within the last 90 days * Able and willing to attend weekly DBT sessions (either virtually or in-person) * Experiencing self-reported psychological distress related to advanced kidney disease or initiation of hemodialysis * Deemed eligible to participate by study clinical psychologist Exclusion Criteria: * Unable to complete intervention due to planned relocation/transplant/modality change * Unable to communicate in English * Deemed by hemodialysis unit staff/physician/study psychologist to be unable to participate fully in study activities due to: * Actively participating in psychiatric care with psychiatric (DSM-5) diagnosis * Requiring referral for psychiatric care as per facility-based HD care provider assessment * Current psychotic symptoms * Cognitive impairment that would limit ability to participate in group or complete homework * Safety risk to staff (e.g. physical aggression) * Antisocial personality disorder or other issues that may limit ability to constructively participate in peer group * Severe comorbid substance use disorder (if present will offer referral to addictions resources or Addictions Psychiatry)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Advanced chronic kidney disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Seven Oaks General Hospital

    Winnipeg, Manitoba, R2V 3M3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.